Grifols | GRFS - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Alaunos Therapeutics USD 2.15M 650K 2025-12
Arca Biopharma USD 469M 17.79M 2025-12
aTyr Pharma USD -24.12M 104.35M 2025-12
Bio Path USD -8M 846K 2025-09
Brainstorm Cell Therapeutics USD -9.98M 2.29M 2025-12
Capricor Therapeutics USD 305.79M 221.92M 2025-12
Cara Therapeutics USD 27.87M 5.06M 2025-09
Esperion Therapeutics USD -301.96M 149.4M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Immunic USD -6.67M 17.17M 2025-12
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
TherapeuticsMD USD 27.67M 990K 2024-06